CClinicalTrials.gg
RecruitingNCT06707792Updated Dec 2, 2024

Validity and Reliability of 6 Minute Stepper Test in Kidney Transplant Recipients

An observational study in Renal Transplanted Recipients, sponsored by Hacettepe University. Recruiting at 1 site in Turkey. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2024-12-02.

Sponsored by Hacettepe University · Observational

From the registry’s dates

  • Primary completion was expected by Jan 2025, 1 year 9 months ago, but the record still lists the study as recruiting.
  • Started Jun 2024; still recruiting 2 years 3 months later.
Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
40
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The aim of our study was to investigate the validity and reliability of the 6 minute stepper test in kidney transplant recipients.

02

Conditions studied

  • Renal Transplanted Recipients
03

In context

Lead sponsor

Hacettepe University is the lead sponsor of 983 studies on the registry; 212 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Kidney transplant recipients will be included.

Inclusion criteria

  • Patients with kidney transplantation
  • At least 6 months after the kidney transplant
  • Not having regular exercise habits
  • Voluntary participation in the study

Exclusion criteria

Exclusion Criteria:

  • Having a musculoskeletal problem that may interfere with the tests
  • Having neurological impairment
  • Having chronic lung disease
  • Having had any cardiovascular event in the last 6 months
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
40 participants (estimated)
Patient registry
No

Groups and cohorts

  • Kidney transplant recipients
06

What researchers measure

Primary outcomes

  1. Exercise capacity

    Exercise capacity will be assessed with a 6 minute stepper test.

    Time frame: Day 1

  2. Exercise capacity

    Exercise capacity will be assessed with a 6 minute walk test.

    Time frame: Day 1

  3. Peripheral muscle strength

    Knee extensor strength will be measured using a portable portable handheld dynamometer.

    Time frame: Day 1

  4. Lower extremity endurance

    It will be evaluated with a one-minute sit to stand test.

    Time frame: Day 1

07

Study locations

1 of 1 sites recruiting
  • Hacettepe University
    Ankara, Turkey
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 2, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06707792
Lead sponsor
Hacettepe University
Responsible party
Merve Firat (Assistant Professor, Kirsehir Ahi Evran Universitesi) — Principal investigator
First posted
Nov 27, 2024
Start date
Jun 9, 2024
Primary completion
Jan 2025 (estimated)
Completion
Dec 2025 (estimated)
Last update
Dec 2, 2024

Study contacts

Merve Firat
Contact
mervefirat@ahievran.edu.tr
+90 850 441 02 44
Naciye Vardar-Yagli
Contact
naciyevardar@yahoo.com
+903123051576

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion